Clinical Trial Update: Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating haploidentical hematopoietic progenitor transplantation with selective in vitro depletion of allo-reactive lymphocytes for high-risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Transplant-Related Hematologic Malignancy | Phase 1 | Status: WITHDRAWN